Can existing legal and ethical norms accommodate biotechnologies which may benefit the recipient but harm the public?
"Sinopsis" puede pertenecer a otra edición de este libro.
Sara Fovargue is a Senior Lecturer in Law at Lancaster University, where she specialises in health care law and ethics. Her main interests are clinical research involving human and non-human animals, risk and regulation with regards to developing biotechnologies and decision-making practices for vulnerable groups within health care law and practice.
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: WorldofBooks, Goring-By-Sea, WS, Reino Unido
Paperback. Condición: Fine. Nº de ref. del artículo: GOR014409255
Cantidad disponible: 1 disponibles
Librería: Better World Books Ltd, Dunfermline, Reino Unido
Condición: Good. Ships from the UK. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages. Nº de ref. del artículo: 45756759-20
Cantidad disponible: 1 disponibles
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
Hardback. Condición: New. Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health. Nº de ref. del artículo: LU-9780521195768
Cantidad disponible: 1 disponibles
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: AR-9780521195768
Cantidad disponible: 15 disponibles
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: AR-9780521195768
Cantidad disponible: 15 disponibles
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Hardcover. Condición: new. Hardcover. Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health. Sara Fovargue explores the law's ability to protect people from the risk posed by xenotransplantation (cross-species transplantation). By exploring regulatory approaches to biotechnologies in the UK and elsewhere, she highlights how such biotechnologies challenge existing legal and ethical norms and how this influences their regulation. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9780521195768
Cantidad disponible: 1 disponibles
Librería: Prior Books Ltd, Cheltenham, Reino Unido
Hardcover. Condición: Like New. First Edition. Firm, square and tight with sturdy hinges, just showing a few minor rubs and some mild cosmetic wear. Hence a non-text page is stamped 'damaged'. Despite such this book is in nearly new condition. Thus the contents are crisp, fresh and clean. Offered for sale at a very sensible price. Nº de ref. del artículo: 118735
Cantidad disponible: 1 disponibles
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Hardback. Condición: New. New copy - Usually dispatched within 3 working days. 670. Nº de ref. del artículo: B9780521195768
Cantidad disponible: Más de 20 disponibles
Librería: Basi6 International, Irving, TX, Estados Unidos de America
Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Nº de ref. del artículo: ABEOCT25-97320
Cantidad disponible: 1 disponibles
Librería: Labyrinth Books, Princeton, NJ, Estados Unidos de America
Condición: Very Good. Nº de ref. del artículo: 148264
Cantidad disponible: 1 disponibles